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IT has been suggested (Jull, 1956, 1958a and b) that certain chemical carcino-
gens may act on the mouse breast in virtue of their similarity to the steroid
hormones which are concerned in the induction of normal proliferation.
20-Methylcholanthrene and 9,10-dimethyl-1,2-benzanthracene share with pro-
gesterone the capacity to stimulate acinar growth in the breast (Jull, 1956) and
it has been demonstrated in the case ofthe mouse (Jull, 1954) and the rat (Sydnor
and Cockrell, 1963) that progesterone stimulation is of critical importance in the
induction of mammary cancer by these compounds. The necessity for pro-
gesterone in the induction of breast cancer by these carcinogens is also indirectly
supported by the findings (Biancifiori, Bonser and Caschera, 1959; Marchant,
1961) that this form ofmammary carcinogenesis is enhanced by pseudopregnancy.
1,2:5,6-Dibenzanthracene (DBA) and 3,4-benzopyrene (BP) have also been
shown to be breast carcinogens (Jull, 1958a), and whilst they exhibit no pro-
gesterone-mimetic activity, they are weak oestrogens. This is evidenced by the
induction of vaginal keratinisation by BP (Cook, Dodds, Hewett and Lawson,
1934) and the stimulation of duct growth in the breast by DBA (Perry, 1938;
Lewis and Turner, 1941).
In the case of DBA, there is already evidence (Gilmour, 1939) that the inci-
dence of breast tumours induced by this compound is increased by oestrone
administration. This augmentation is for some reason greater when oestrone is
given to intact DBA treated mice than when ovariectomised mice are subjected to
this dual treatment.
The present experiments were designed to confirm the earlier findings and to
observe the effects of breeding or pseudopregnancv on this form of mammary
tumour induction.
METHODS
C3Hb mice of the Leeds strain (Biancifiori, Bonser and Caschera, 1961) were
used in all the experiments. At the time of application of the carcinogen they
were between 3 and 5 months of age.
All mice received 8 skin paintings at weekly intervals with 16 drops of an
0-25 per cent solution of the carcinogen in sweet almond oil. The estimated
amount ofthe chemical admiinistered at each treatmeint was 2 mg.
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Group 1 were maintained as virgins.
Group 2 received oestrone in their drinking water at a concentration of 1 mg./1.
throughout the experiment.
Group 3 were kept in the presence of vasectomised males and were assumed
to be pseudopregnant.
Group 4 (normal breeding) were mated with normal males and allowed to bear
and suckle their litters, the number of litters per mouse varied from 1 to 10 with
an average of 3.4.
Group 5 (forced breeding) were mated with normal males, their litters being
destroyed within 24 hours of birth. Due to an earlier mortality from infection
in this group the average number of litters was only 14 per mouse, the range
being from 0 to 6.
Mice were killed when death appeared imminent, when there were large
mammary tumours or to terminate the experiment.
Representative portions of breast, uterus, ovaries and all tumours were fixed
in Bouin's fixative, sectioned and stained with haematoxylin and eosin.
RESULTS
The times at which breast tumours arose in the various groups are listed in
Table I. Mice were visually inspected routinely but not palpated for breast
tumours, so the times of appearance may often have been earlier than stated.
The tumour incidences are calculated on the number of mice alive at the time of
detection of the first tumour in that group.
Mammary cancers occurred in all groups of mice, but the incidence and latent
period varied considerably with the hormonal environment. There were breast
tumours in 57 per cent of the pseudopregnant mice by 40 weeks, significantly
more than the 25 to 32 per cent which had appeared by this time in mice sub-
jected to oestrone administration, normal or forced breeding. The first breast
tumour in the virgin mice was not observed until 50 weeks.
TABLE I.-Incidence of Mammary Tumours in Female C3Hb Mice Treated for
8 Weeks with 1,2: 5,6-dibenzanthracene (DBA)
Mainmary cancer
incidence
At 40
weeks Finnl
Hormonal 21- 26- 31- 36- 41- 46- 51- 56- 61- 65-
state 25 30 35 40 45 50 55 60 65 70 70+ No. % No. %
Normal 0/22 0/22 0/22 0/22 0/22 2/20 1/17 1/15 0/15 1/9 0/4 0/22 0 5/20 25
virgin
Virgin + 0/22 0/22 0/22 4/20 0/18 1/15 3/12 0/11 1/11 0/3 0/1 4/20 25 9/20 45
oestrone
Pseudo- 0/14 3/14 3/13 2/13 2/11 2/6 0/5 0/3 0/1 - 8/14 57 12/14 86
pregnant
. Normal 1/34 3/31 3/31 4/25 3/20 1/18 2/18 2/15 1/10 0/9 - 11/34 32 20/34 59
breeding
. Forced . 0/23 0/18 0/13 4/13 0/9 --. 4/13 30 4/13 30
breeding
Numerator: Number of mice whose first mammary tumour arose in this period,
Denominator: Number of mice alive at the beginning of the period.
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The final incidence of mammary cancer was similar in the oestrone-treated
and breeding mice although the latent period was 13 weeks shorter in the latter
group. The decreased survival in the forced-breeding mice (group 5) was due
to a greater incidence of pulmonary and intestinal infection and accounts for the
lower proportion of mammary cancer as compared to groups 2 to 4.
There were mice with more than one breast tumour in each of groups 1 to 4.
The time ofappearance ofmultiple tumours was after 50 weeks, and this accounts
for their absence in group 5, all of which were dead by this time.
Structurally all the breast tumours were adenocarcinomas similar to those
induced by the milk agent, consisting either of small tubules or irregular tubules
with papillary outgrowth and cyst formation. In a few of the tumours there
was some increase of the stromal element. In many breasts containing tumours
there were small groups of ducts and acini undergoing squamous metaplasia, but
these could not be regarded as the origin of the fully developed tumours, as no
tumours had any major squamous components. Small foci of squamous meta-
plasia were seen in 5 of the 25 tumours occurring in groups 1, 2 and 3, but none
occurred in any of the 23 tumours ofgroups 4 and 5. It may be that the greater
degree of secretion in the last two groups was inhibitory to this form of meta-
plasia.
Small foci indistinguishable from granulosa cell tumours occurred in normal
sized or atrophic ovaries of 4 virgin and 4 breeding mice and one was found in a
mouse treated with oestrogen. The earliest of these foci was seen after 59 weeks
of treatment. Such lesions are not uncommon in untreated mice of this strain.
Adenocarcinoma of the uterus was seen in one virgin mouse 67 weeks after
the start of treatment.
Squamous carcinomas of the skin occurred in a number of mice of all groups
but they did not interfere with the objects of the experiments.
DISCUSSION
Since the early work of Perry and Ginzton (1937) and Gilmour (1939), there
have been only a few reports of the induction of mammary tumours by 1,2: 5,6-
dibenzanthracene. Jull (1958) reported an incidence of 43 per cent in virgin IF
mice given 4 fortnightly skin applications of an 0-25 per cent solution of this
compound in arachis oil, and Biancifiori et al. (1961) found 4 breast tumours in
15 virgin female C3Hb mice treated 8 times at weekly intervals by skin painting,
but none arose in 15 mice treated for 8 weeks with the carcinogen by stomach
tube.
Recently Ranadive and Karande (1963) have reported the incidence of mam-
mary tumours in virgins and breeding females of five strains painted bi-weekly
with an 0-25 per cent solution of DBA in benzene. They found a significant
increase in breast tumours in both breeders and virgins of the dba (-MTI) strain,
C3H virgins and L(P) breeders. No breast tumours were seen in the C57 strain.
They observed no increase in breast tumour incidence in C3H breeders but this
was presumably masked by the presence of the milk agent which gives nearly
100 per cent of mammary cancer in this strain. The findings of one breast
tumour among 11 painted virgin Strong A mice and one among 13 painted virgin
L(P) mice are not significant. The fact that no breast tumours were seen in
12 painted breeding Strong A mice, whereas 3 occurred in 11 control breeders, is
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interesting. This possible suppression of milk agent induced tumours is worth
further inquiry. Unfortunately these authors do not record the time at which
breast tumours were first observed. Also of interest is the observation that the
number of corpora lutea was significantly reduced in the ovaries of both breeding
and virgin dba mice treated with DBA.
The experiments reported in the present communication confirm the early
observations of Perry and Ginzton (1937) and of Gilmour (1939), that oestrogen
administration increases the carcinogenicity of DBA for the mouse breast. They
also demonstrate that a similar augmentation follows forced or normal breeding,
the greatest increase occurring in pseudopregnant mice.
Although the results in pregnant or pseudopregnant mice are compatible with
the possibility that mammary carcinogenesis by DBA is augmented by oestrogen
it could equally well be that the increase is due to enhanced progesterone secretion
in these conditions. One reason for supposing that the hormonal requirements
with DBA are different from those of MC, however, is the fact that in the C57
strain pseudopregnancy greatly increased the incidence of breast tumours after
MC treatment, but no significant increase was observed in pseudopregnant C57
mice treated with DBA (Marchant, 1963).
The original observation of Perry and Ginzton, that the stimulation of mam-
mary carcinogenesis by oestrone is most marked in the presence of the ovary,
indicates a synergism with some other hormonal factor or a difference in oestrone
or DBA metabolism in the castrate. More detailed studies are necessary of the
hormonal requirements in mammary carcinogenesis by DBA, for comparison with
the data on induction of breast tumours by MC. It seems likely that the
mechanisms by which these two compounds produce cancer are fundamentally
different.
SUMMARY
Mammary cancer was induced in female C3Hb mice painted 8 times at weekly
intervals with an 0-25 per cent solution of 1,2: 5,6-dibenzanthracene in oil.
There was a greater incidence of breast tumours in mice subjected to pseudo-
pregnancy (86 per cent), normal breeding (59 per cent), oestrone administration
(45 per cent) or forced breeding (30 per cent), than there was in normal virgins
(25 per cent). These changes in hormonal environment also reduced the latent
period of tumour induction.
All the breast tumours were adenocarcinomas similar in structure to those
induced by the milk agent. Squamous metaplasia was seen in the breasts of
virgin, pseudopregnant and oestrone treated mice.
I wish to thank Dr. G. M. Bonser for her very great help in the histological
assessment of the tumours and other tissues.
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